NP/PA Connect

News
Media
Conferences
Events
Publication
CME/CE
Resources
Editorial Advisory Board
Partners
Subscribe

Bruce Strober, MD, PhD

Articles by Bruce Strober, MD, PhD

UPCOMING SERIES: Efficacy and Safety of Subcutaneous Spesolimab for the Prevention of Generalised Pustular Psoriasis Flares (Effisayil 2): an International, Multicentre, Randomised, Placebo-Controlled Trial

ByBruce Strober, MD, PhD,Aaron S. Farberg, MD

September 30th 2024

Latest Updated Articles

Trending on Dermatology Times

Recludix Pharma’s REX-8756 for Type 2 Inflammatory Diseases Enters First Human Trials

Oruka Reports Positive Interim Phase 1 Data for ORKA-002, Advances ORKA-001

Alpha Tau Submits First PMA Module to FDA for Novel cSCC Treatment, Alpha DaRT

Next-Generation IL-4Rα Targeting and Potential Dermatologic Implications

Comparative Analysis Positions Zasocitinib Among Next-Generation TYK2 Inhibitors